Rising Demand for Pain Management Therapeutics: Market Opportunities in 2029 Chronic pain instances have increased in recent years as a result of chronic diseases becoming more common. There is an increasing need for effective pain management treatments due to the increased concern over pain brought on by chronic illnesses. According to the National Institutes of Health (NIH), 1 in 10 people in the United States alone experience chronic diseases and the resulting pain. Additionally, the rise in cancer cases around the world has increased the demand for painkillers. The need for opioids, NSAIDs (Non-Steroidal Anti-Inflammatory Drugs), anaesthetics, and anticonvulsants has increased as a result of cancer-related pain. The World Health Organisation (WHO) predicts a 75% increase in cancer cases globally by 2050, according to the National Institute of Cancer, which recorded roughly 1,735,350 registered cancer cases in the United States in 2018.
For more information, please refer to the full report: https://www.fairfieldmarketresearch.com/report/pain-management-therapeutics-market The Growing Pain Management Therapeutics Market The global pain management therapeutics market was valued at around US$ 65 billion in 2018 and is projected to grow at a rate of over 4% in the next six years, reaching a market value of over US$ 85 billion. Among the various therapeutics available, opioids are anticipated to witness high traction as the leading medication for pain management. Opioids have proven to be highly efficient in treating cancerrelated pain. These medications, containing synthetic and natural opiates, offer effective solutions for acute pain, short-term pain, and pain associated with surgeries or trauma. Consequently, opioids are the most prescribed medications in pain management, contributing to a significant revenue share in the market. North America's Dominance in the Pain Management Therapeutics Market